Sign Out
Nicotine passes to the foetus and affects its breathing movements and circulation. The effect on the circulation is dose-dependent. Therefore the pregnant smoker should always be advised to stop smoking completely without the use of nicotine replacement therapy. The risk of continued smoking may pose greater hazard to the foetus as compared with the use of nicotine replacement products in a supervised smoking cessation programme. Use of Nicorette lnvisi Transdermal Patch by the pregnant smoker should only be initiated after advice from a healthcare professional.
Nicotine passes freely into breast milk in quantities that may affect the child, even with therapeutic doses. The use of Nicorette lnvisi Transdermal Patch should therefore be avoided when breastfeeding. Should smoking cessation not be achieved, use of the Nicorette lnvisi Transdermal Patch by breastfeeding smokers should only be initiated after advice from a healthcare professional.
